AIMA is worried the EMIR proposals will create new barriers to international clearing. While it strongly supports mandatory clearing of eligible OTC derivatives, it wants the EU policymakers to reconsider those parts of the EMIR proposals that would exclude EU-established firms from using non-EU central counterparties. (Source: AIMA Press Release on EMIR Clearing Barriers)